Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs
- PMID: 28552995
- PMCID: PMC5445925
- DOI: 10.1257/aer.p20171086
Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs
Figures
References
-
- Chandra Amitabh, Skinner Jonathan. Technology Growth and Expenditure Growth in Health Care. Journal of Economic Literature. 2012;50(3):645–680.
-
- Cockburn Iain, Lanjouw Jean, Schankerman Mark. Global Diffusion of New Drugs: The Role of Patent Policy, Price Controls and Institutions. American Economic Review. 2016;106(1):136–164. - PubMed
-
- Danzon Patricia M, Wang Richard, Wang Liang. The Impact of Price Regulation on the Launch Delay of New Drugs – Evidence from Twenty-five Major Markets in the 1990s. Health Economics. 2005;14:269–292. - PubMed
-
- Kyle Margaret. Pharmaceutical Price Controls and Entry Strategies. Review of Economics and Statistics. 2007;89(1):88–99.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources